Phimo International to Invest $159.7 Million in Philippines for Tobacco Production.

Oct.12.2022

Phimo International to invest $159.7 million to establish a production plant for heating tobacco devices in the Philippines.

According to reports, Femto International will invest $159.7 million in the Philippines to establish a production site for manufacturing heating cigarette devices and heating tobacco sticks.

Phimo International is set to produce heated tobacco sticks in the Philippines for the first time. It is estimated that over 20% of adults in the Philippines smoke. Phimo International stated that this investment will use tobacco leaves grown in the Philippines and create 220 employment opportunities.

#Philippines #Product #Products of Tobacco

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Why Many E-Liquids Today Are "Not Bad, but Not Memorable" – Mylor’s Approach to Experience Design

Why Many E-Liquids Today Are "Not Bad, but Not Memorable" – Mylor’s Approach to Experience Design

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

EVO NXT European Tobacco & NGP Exhibition

EVO NXT European Tobacco & NGP Exhibition

Bulgaria’s Disposable Vape Ban Receives Formal Approval From the European Commission

Bulgaria’s Disposable Vape Ban Receives Formal Approval From the European Commission

The European Commission has formally published its decision approving Bulgarian legislation banning the placing on the market, offering and sale of disposable e-cigarettes.

Mar.17 by 2FIRSTS.ai

Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them

Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them

Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.

Apr.23 by 2FIRSTS.ai

2Firsts｜Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window

2Firsts｜Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window

Sesh said its Premarket Tobacco Product Application (PMTA) for 64 nicotine pouch SKUs has been accepted by the U.S. Food and Drug Administration (FDA) and advanced to the Filing stage, entering substantive scientific review. Industry experts say the development signals that the application has crossed a key technical and regulatory threshold, while also highlighting growing divergence in regulatory capability and market positioning within the nicotine pouch category.

Mar.24 by 2FIRSTS.ai

Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process

Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process

Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.

FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation

FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation

The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.

May.07 by 2FIRSTS.ai

PML Expands Its UK Smoke-Free Portfolio With LEVIA

PML Expands Its UK Smoke-Free Portfolio With LEVIA

Philip Morris Limited has launched LEVIA, a new range of zero-tobacco flavored nicotine sticks created for the IQOS ILUMA range. The product expands the company’s smoke-free portfolio in the UK and will initially be available in four variants, including Deep Mint and three capsule-based flavors. LEVIA has a recommended retail price of £5, or about $6.73, based on the European Central Bank’s April 28.

Apr.29 by 2FIRSTS.ai

Related Topics

News

Related Read

Bulgaria’s Disposable Vape Ban Receives Formal Approval From the European Commission

Bulgaria’s Disposable Vape Ban Receives Formal Approval From the European Commission

Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them

Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them

2Firsts｜Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window

2Firsts｜Sesh Advances Nicotine Pouch PMTA to Filing Stage, Experts Highlight Regulatory Threshold and Market Window

Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process

Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process

FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation

FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation

PML Expands Its UK Smoke-Free Portfolio With LEVIA

PML Expands Its UK Smoke-Free Portfolio With LEVIA